DNA and RNA sample preparation provides accessibility to nucleic acids in a natural form and removes unwanted contaminants. DNA and RNA sample preparation process has become highly refined and multi-national companies are focusing on faster and accurate products. Market players are focused on launching automated workstations to enable faster, refined, and consistent DNA and RNA extraction. These workstations are compatible with various kits, reagents and lab ware.
The global DNA and RNA sample preparation market is estimated to account for US$ 1,541.3 Mn in terms of value in 2018 and is expected to reach US$ 2,327.7 Mn by the end of 2027.Increasing funding in life science research is expected to boost growth of the global DNA and RNA sample preparation market over the forecast period. For instance, in February 2020, Purdue-affiliated Amplified Sciences LLC and Brightlamp Inc. received approvals for up to US$ 250,000 each from the Purdue Foundry Investment Fund for R&D in life science technologies.
We do offer sample of this report. Kindly go through the follow information in order to access sample copy:- https://www.coherentmarketinsights.com/insight/request-sample/3620
Moreover, collaborative efforts and initiatives to identify therapies for difficult-to-treat illnesses is also expected to aid in growth of the market. For instance, in February 2020, Cellectricon (Molndal), a Sweden–based pharmaceutical company collaborated with StressMarq Biosciences, a Canada-based life sciences reagents supplier, for R&D in neurodegenerative diseases.North America region held dominant position in the global DNA and RNA sample preparation market in 2018, accounting for 40.6% share in terms of value, followed by Europe.High cost of products and low investments are expected to hinder growth of the global DNA and RNA sample preparation market. Researches in the life science sector are complex and have uncertainties in terms results. This in turn increases R&D and product cost and deters users from investing in such expensive products.
Moreover, challenges in handling RNA are also expected to limit growth of the market. The presence of RNases is a major challenge in isolating, manipulating, or analyzing RNA. RNases are extremely stable and very active nucleases capable of degrading the RNA.
Using quality control tools to obtain information on nucleic acid quantification, integrity, and sizing of fragments in next-generation sequencing is expected to offer lucrative growth opportunities for players in the market. Quality control tools can aid in maintaining clean samples that are free from contaminants.
Moreover, market players can also focus on digitalization in the life science sector through adoption of technologies such as wearable devices and artificial intelligence. Digital technology can be used for routine tasks such regulatory filings. DNA sample preparation segment in the global DNA and RNA sample preparation market was valued at US$ 570.9 Mn in 2018 and is expected to reach US$ 932.0 Mn by 2027 at a CAGR of 5.5% during the forecast period.The market is witnessing emergence of new field of scientific investigation in the form of RNA interference (RNAi). It is a biological process targeted mRNA molecules are neutralized to inhibit gene expression or translation in RNA molecules.
Major companies are focused on R&D in COVID-19 virus. For instance, in February 2020, Covaris, Inc. launched two new kits for viral RNA extraction from nasal or throat swab sample collection devices that include truXTRAC Viral RNA Extraction kit using Puritan Swabs and truXTRAC-PCR Direct Viral RNA Extraction kit.
Major players operating in the global DNA and RNA sample preparation market include, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., DiaSorin S.p.A, F. Hoffmann-La Roche, Miroculus, Inc., Illumina, Inc., PerkinElmer, Inc., QIAGEN, Sigma Aldrich Corp., Tecan Group AG, and Thermo Fisher Scientific, Inc.
Major players in the market are focused on launching new products to expand their product portfolio. For instance, in February 2020, Miroculus, Inc. launched Miro Canvas, a system that can simplify, automate, and miniaturize complex protocols such as next generation sequencing library preparation, at the Advances in Genome Biology and Technology conference held in the U.S.
Major players in the market are also focused on adopting collaboration strategies to expand their product portfolio. For instance, in March 2020, Fluidigm Corporation, a provider of microfluidics technology, partnered with Next Gen Diagnostics, a provider of automation in pathogen bioinformatics, under which the later will use the Fluidigm Juno system for pathogen whole genome sequencing sample preparation in exchange of milestone payments starting in 2020 and additional revenue to Fluidigm Corp.
Get the main link:- https://www.coherentmarketinsights.com/market-insight/dna-and-rna-sample-preparation-market-3620
ContactUs:
Mr.Shah
Coherent Market ,Insights
10014thAve,
#3200
Seattle,WA98154
Tel:+1-206-701-6702
Email: [email protected]